 - Patients scheduled for first cytotoxic chemotherapy cycle, regardless of the line of treatment, because of hematologic malignancies at intermediate or high risk of TLS according to the TLS risk stratification, Cairo M et al, British Journal of Haematology, 2010candidate to Allopurinol treatment or have no access to Rasburicase 